Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

MindMaze Therapeutics Holding SA

MMTX.S ✗ NOT COMPLIANT ☆ Track — members

SIX Swiss Exchange · Healthcare · Biotechnology & Medical Research ·

Switzerland Micro Cap Analyst: STRONG BUY

Last Close

$0.25

▼ -9.89%

Market Cap $45.91M · Vol 787.78K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$45.91M

Micro Cap

Div Yield

N/A

Annual dividend

EPS Growth

+83.49%

YoY

RSI (14)

53.25

Momentum

Beta

-0.32

vs Market

52W High

$5.53

95.49% below

52W Low

$0.19

35.73% above

Volume

787.78K

Avg 1.23M

P/B

7.56

Price-to-book

ROE

N/A

Return on equity

Free Float

38.83%

Public shares

Shariah Compliance8 STANDARDS

✗ MindMaze Therapeutics Holding SA (MMTX.S) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does MMTX.S pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-12.21%

+27.17%

-47.84%

-80.29%

YTD

-89.21%

-92.60%

-88.96%

-99.73%

Financials & Valuation

TTM · Annual

Total Revenue	$810.30K
Net Income	$-12,502,840.00
Revenue Growth (YoY)	N/A
Gross Margin	92.06%
Operating Margin	-1,637.85%
Net Profit Margin	-1,542.99%
ROE	N/A
ROA · ROIC	-18.91% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	61.11
P/B	7.56
P/FCF	N/A
EPS Growth	+83.49%
Outstanding Shares	181.50M

Technical Indicators

50-Day SMA	$0.26
200-Day SMA	$1.24
RSI (14)	53.25
Beta	-0.32
52-Week High	$5.53
52-Week Low	$0.19

Volume Today	787.78K
Avg Daily Volume (30D)	1.23M
Relative Volume	0.64x
Volatility (10D)	94.68
Volatility (30D)	101.72
Free Float	38.83%

Analyst Consensus

STRONG BUY

Current Price $0.25

Mean Target N/A

52W Low$0.19 52W High$5.53

Current

Target

$0.19 $5.53

Current Analyst target

· 2 analysts

Identifiers

ExchangeSIX Swiss Exchange

FIGIBBG001SLFQ79

ISINCH1251125998

CountrySwitzerland

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG -0.11% RVMD Revolution Medicines Inc +1.89% ONC BeOne Medicines AG +1.83% 068270.KS Celltrion Inc -2.74% ABVX Abivax SA -1.48%

Company Profile

MindMaze Therapeutics Holding SA, formerly known as RELIEF THERAPEUTICS Holding SA, is a Switzerland-based company that engages in research, development, production, and sale of biotechnology, pharmaceutical, diagnostic, therapeutic, chemical, and cosmetic products. The Company acquires and manages patents, licenses, and intellectual property, provides preclinical, clinical, and regulatory services, and may establish subsidiaries worldwide. The Company also participates in the acquisition, holding, and financing of interests in companies, offers management services to affiliates, and develops scientific and economic solutions for disease treatment and therapeutic approaches. Additionally, the Company may acquire, hold, and sell trademarks and other IP rights globally, and provide or obtain financing through loans or guarantees to support its corporate purpose.